Skip to content
‹ Back to IndustriesSciences

Increasing Diversity in STEM Means Creating More Early Education Opportunities for STEM Exposure

It is no secret that STEM fields have long been lacking in diversity. Even as women have become the majority of holders for undergraduate degrees, they still are underrepresented in STEM. For example, recent research from the National Center for Science and Engineering Statistics shows meager progress on diversity in STEM; the STEM workforce…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Diversity in StemEducationHigh SchoolsInequity
Share

Key takeaways

01

It is no secret that STEM fields have long been lacking in diversity.

02

Even as women have become the majority of holders for undergraduate degrees, they still are underrepresented in STEM.

03

For example, recent research from the National Center for Science and Engineering Statistics shows meager progress on diversity in STEM; the STEM workforce…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

It is no secret that STEM fields have long been lacking in diversity. Even as women have become the majority of holders for undergraduate degrees, they still are underrepresented in STEM. For example, recent research from the National Center for Science and Engineering Statistics shows meager progress on diversity in STEM; the STEM workforce is still largely dominated by white professionals, men, and able-bodied individuals. While there’s been progress over the last decade, it’s slow to bare out in the actual spread of socioeconomic demographics.

The issue of diversity in STEM in part starts long before undergrad in high schools. Public school’s funding can vary dramatically, even between geographically close schools. That level of funding can directly impact student’s access to internships, mentors, and academic experiences especially within the STEM field.

Some professionals in STEM fields and the larger sciences industry are taking solutions into their own hands through the launch of nonprofit localized education centers which aim to bring science, technology, engineering and math education to K-12 students. It’s exactly what Reedy Wade, the Vice President of Academy Engagement and Impact at career readiness nonprofit NAF, is working to implement across the communities she and her team serve.

Reedy’s Thoughts

“While today’s job landscape comes with challenges, inequities, and economic and social disparities that have marginalized far too many students in this country, NAF is committed to bringing schools and businesses together to ensure that students, particularly girls of color, are supported, prepared, and inspired to pursue and achieve careers in STEM.

It truly all begins with exposure to the right academic experiences, the right internship, the right mentor and connections or just having access to the right door at the right time. With greater access and opportunity to participate in work-based learning and connect with mentors who help them build their aspirations, high school students, especially those in under-resourced communities, can move toward a life of upward economic mobility and success.”

Article written by Graham P. Johnson.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512